Annual Cash & Cash Equivalents
$73.68 M
-$20.56 M-21.82%
December 31, 2023
Summary
- As of February 8, 2025, OPTN annual cash & cash equivalents is $73.68 million, with the most recent change of -$20.56 million (-21.82%) on December 31, 2023.
- During the last 3 years, OPTN annual cash & cash equivalents has fallen by -$70.47 million (-48.89%).
- OPTN annual cash & cash equivalents is now -68.63% below its all-time high of $234.85 million, reached on December 31, 2017.
Performance
OPTN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$82.50 M
-$8.86 M-9.70%
September 30, 2024
Summary
- As of February 8, 2025, OPTN quarterly cash and cash equivalents is $82.50 million, with the most recent change of -$8.86 million (-9.70%) on September 30, 2024.
- Over the past year, OPTN quarterly cash and cash equivalents has dropped by -$8.86 million (-9.70%).
- OPTN quarterly cash and cash equivalents is now -66.33% below its all-time high of $244.99 million, reached on June 30, 2018.
Performance
OPTN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
OPTN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.8% | -9.7% |
| 3 y3 years | -48.9% | +35.1% |
| 5 y5 years | -63.3% | -42.4% |
OPTN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.3% | at low | -25.3% | +59.7% |
| 5 y | 5-year | -49.9% | at low | -44.4% | +59.7% |
| alltime | all time | -68.6% | +384.8% | -66.3% | +124.2% |
OptiNose Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $82.50 M(-9.7%) |
| Jun 2024 | - | $91.36 M(+76.9%) |
| Mar 2024 | - | $51.64 M(-29.9%) |
| Dec 2023 | $73.68 M(-21.8%) | $73.68 M(+10.2%) |
| Sep 2023 | - | $66.84 M(-6.3%) |
| Jun 2023 | - | $71.31 M(-15.0%) |
| Mar 2023 | - | $83.93 M(-10.9%) |
| Dec 2022 | $94.24 M(-14.7%) | $94.24 M(+54.3%) |
| Sep 2022 | - | $61.08 M(-22.0%) |
| Jun 2022 | - | $78.26 M(-14.3%) |
| Mar 2022 | - | $91.37 M(-17.3%) |
| Dec 2021 | $110.50 M(-23.3%) | $110.50 M(+31.2%) |
| Sep 2021 | - | $84.23 M(-10.3%) |
| Jun 2021 | - | $93.92 M(-19.0%) |
| Mar 2021 | - | $115.98 M(-19.5%) |
| Dec 2020 | $144.16 M | $144.16 M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2020 | - | $143.13 M(+14.3%) |
| Jun 2020 | - | $125.27 M(-15.6%) |
| Mar 2020 | - | $148.47 M(+0.9%) |
| Dec 2019 | $147.14 M(-26.8%) | $147.14 M(+17.3%) |
| Sep 2019 | - | $125.49 M(-12.8%) |
| Jun 2019 | - | $143.96 M(-16.0%) |
| Mar 2019 | - | $171.32 M(-14.8%) |
| Dec 2018 | $200.99 M(-14.4%) | $200.99 M(-9.3%) |
| Sep 2018 | - | $221.49 M(-9.6%) |
| Jun 2018 | - | $244.99 M(+16.8%) |
| Mar 2018 | - | $209.77 M(-10.7%) |
| Dec 2017 | $234.85 M(+538.2%) | $234.85 M(+375.3%) |
| Sep 2017 | - | $49.41 M(-16.1%) |
| Jun 2017 | - | $58.89 M(+60.0%) |
| Dec 2016 | $36.80 M(+142.1%) | $36.80 M |
| Dec 2015 | $15.20 M | - |
FAQ
- What is OptiNose annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for OptiNose?
- What is OptiNose annual cash & cash equivalents year-on-year change?
- What is OptiNose quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for OptiNose?
- What is OptiNose quarterly cash and cash equivalents year-on-year change?
What is OptiNose annual cash & cash equivalents?
The current annual cash & cash equivalents of OPTN is $73.68 M
What is the all time high annual cash & cash equivalents for OptiNose?
OptiNose all-time high annual cash & cash equivalents is $234.85 M
What is OptiNose annual cash & cash equivalents year-on-year change?
Over the past year, OPTN annual cash & cash equivalents has changed by -$20.56 M (-21.82%)
What is OptiNose quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of OPTN is $82.50 M
What is the all time high quarterly cash and cash equivalents for OptiNose?
OptiNose all-time high quarterly cash and cash equivalents is $244.99 M
What is OptiNose quarterly cash and cash equivalents year-on-year change?
Over the past year, OPTN quarterly cash and cash equivalents has changed by -$8.86 M (-9.70%)